Drug interactions for the following drug(s)

Add New Drugs

Interactions between your selected drugs

Moderate

methotrexate<>bismuth subsalicylate

Applies to: methotrexate 50 MG in 2 ML Injection <> Pepto-Bismol 262 MG Chewable Tablet

The serum concentration of Methotrexate can be increased when it is combined with Bismuth subsalicylate.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Moderate

methotrexate<>bismuth subsalicylate

Applies to: methotrexate 50 MG in 2 ML Injection <> Pepto-Bismol 262 MG Chewable Tablet

Drug1 (rxcui = 1655960, name = 2 ML methotrexate 25 MG/ML Injection, tty = SCD). Drug2 (rxcui = 211151, name = bismuth subsalicylate 262 MG Chewable Tablet [Pepto-bismol], tty = SBD). Drug1 is resolved to methotrexate, Drug2 is resolved to bismuth subsalicylate and interaction asserted in DrugBank between Methotrexate and Bismuth subsalicylate.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

DrugInteractionChecker.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 28th, 2016), Cerner Multum™ (updated Oct 2nd, 2016), Wolters Kluwer™ (updated Oct 1st, 2016) and others. To view content sources and attributions, please refer to our editorial policy.